Artículos de revistas sobre el tema "Pancancer"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Pancancer".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Wong, Chi Chun y Jun Yu. "Mapping the pancancer metastasis tumor microbiome". Cell 187, n.º 9 (abril de 2024): 2126–28. http://dx.doi.org/10.1016/j.cell.2024.03.040.
Texto completoKappmeier, Claudia, Sherina Edward, Corinna Hochstein, Ellen Inga Bruske, Francesca Di Pasquale y Ronny Kellner. "Abstract 1470: Advancing cancer research: A novel PanCancer digital PCR tool for simultaneous detection of multiple hallmark mutations in BRAF and EGFR". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 1470. http://dx.doi.org/10.1158/1538-7445.am2024-1470.
Texto completoLi, Fei, Jing Chen, Xiaoyan Zhang, Dongxiao Yang, Liang Xia, Dazhong Wang, Kai Jin et al. "Characterization of MET exon 14 skipping in pancancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e20530-e20530. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e20530.
Texto completoCheerla, Anika y Olivier Gevaert. "Deep learning with multimodal representation for pancancer prognosis prediction". Bioinformatics 35, n.º 14 (julio de 2019): i446—i454. http://dx.doi.org/10.1093/bioinformatics/btz342.
Texto completoLiu, Kui, Jing Ma, Jiao Ao, Lili Mu, Yixian Wang, Yue Qian, Jin Xue y Wei Zhang. "The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis". Journal of Oncology 2021 (27 de octubre de 2021): 1–15. http://dx.doi.org/10.1155/2021/2986444.
Texto completoJiang, Aimin, Ye Zhou, Wenliang Gong, Xin Pan, Xinxin Gan, Zhenjie Wu, Bing Liu, Le Qu y Linhui Wang. "CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types". Oxidative Medicine and Cellular Longevity 2022 (31 de marzo de 2022): 1–35. http://dx.doi.org/10.1155/2022/5910575.
Texto completoKarpova, Alla, Nadezhda V. Terekhanova, Siqi Chen, Reyka G. Jayasinghe, Andrew Houston, Wagma Caravan, Ryan C. Fields y Li Ding. "Abstract 2627: PanCancer epigenetic regulators of lymphocyte activation states". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 2627. http://dx.doi.org/10.1158/1538-7445.am2024-2627.
Texto completoJi, Haizhou, Mi Ren, Tongyu Liu y Yang Sun. "Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment". Disease Markers 2021 (19 de noviembre de 2021): 1–21. http://dx.doi.org/10.1155/2021/5350232.
Texto completoCooper, Lee AD, Elizabeth G. Demicco, Joel H. Saltz, Reid T. Powell, Arvind Rao y Alexander J. Lazar. "PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective". Journal of Pathology 244, n.º 5 (22 de febrero de 2018): 512–24. http://dx.doi.org/10.1002/path.5028.
Texto completoNorton, John T., Callie B. Pollock, Chen Wang, Julian C. Schink, J. Julie Kim y Sui Huang. "Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy". Cancer 113, n.º 4 (15 de agosto de 2008): 861–69. http://dx.doi.org/10.1002/cncr.23632.
Texto completoChen, Hao, Fan Xu, Anqi Qin, Shuai Guo, Ge Zhang, Bo Yu y Quanhui Zheng. "A pancancer analysis of histone deacetylase 3 in human tumors". Translational Cancer Research 13, n.º 1 (enero de 2024): 65–80. http://dx.doi.org/10.21037/tcr-23-1228.
Texto completoYu, Xiaoqing, Song Li, Ling Cen y Xuefeng Wang. "Abstract 3557: A pancancer gamma delta T cell repertoire atlas". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 3557. http://dx.doi.org/10.1158/1538-7445.am2024-3557.
Texto completoWu, Yunhui, Jingying Zhang, Can Hou, Hongyu Wang, Min Zhu y Xin Yao. "A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors". Journal of Oncology 2022 (14 de junio de 2022): 1–15. http://dx.doi.org/10.1155/2022/6725570.
Texto completoPeng, Ge, Saya Tsukamoto, Ko Okumura, Hideoki Ogawa, Shigaku Ikeda y François Niyonsaba. "A Pancancer Analysis of the Oncogenic Role of S100 Calcium Binding Protein A7 (S100A7) in Human Tumors". Biology 11, n.º 2 (11 de febrero de 2022): 284. http://dx.doi.org/10.3390/biology11020284.
Texto completoAharonov, Ranit, Gal Dinstag, Eldad Shulman, Efrat Elis, Doreen Ben-Zvi, Omer Tirosh, Danh-Tai Hoang et al. "ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e13556-e13556. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e13556.
Texto completoAharonov, Ranit, Gal Dinstag, Eldad Shulman, Efrat Elis, Doreen Ben-Zvi, Omer Tirosh, Danh-Tai Hoang et al. "ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): e13556-e13556. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e13556.
Texto completoSwami, Nishwant, Edward Christopher Dee, Brandon A. Mahal, Fumiko Chino y Narjust Duma. "Financial toxicity in Hispanic cancer survivors: A nationally representative pancancer analysis." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 6528. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.6528.
Texto completoCui, Jing, Yongjie Tian, Tianhang Liu, Xueyan Lin, Lanyu Li, Zhonghui Li y Liang Shen. "Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy". Disease Markers 2022 (9 de septiembre de 2022): 1–18. http://dx.doi.org/10.1155/2022/5447017.
Texto completoWu, Changwu, Yingjuan Duan, Siming Gong, Sonja Kallendrusch, Nikolas Schopow y Georg Osterhoff. "Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)". International Journal of Molecular Sciences 22, n.º 14 (9 de julio de 2021): 7374. http://dx.doi.org/10.3390/ijms22147374.
Texto completoYang, Jing, Xiaojing Liu, Yueqin Shao, Hong Zhou, Lijun Pang y Wei Zhu. "Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis". Computational and Mathematical Methods in Medicine 2022 (8 de diciembre de 2022): 1–19. http://dx.doi.org/10.1155/2022/3764914.
Texto completoFox, Eleonore, Guillaume Appe, Abdelkader Behdenna, Lea Meunier, Akpeli Nordor, Solene Weill y Camille Marijon. "Abstract 1915: A scalable pancancer antigen target discovery platform for precision oncology". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 1915. http://dx.doi.org/10.1158/1538-7445.am2024-1915.
Texto completoYe, Tao, Lan-lan Li, Xue-mei Peng y Qin Li. "CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis". Disease Markers 2021 (29 de diciembre de 2021): 1–8. http://dx.doi.org/10.1155/2021/8565943.
Texto completoNguyen, Phuong Thao, Yudai Shimojukkoku, Yuka Kajiya, Yasunobu Oku, Ayami Tomishima, Kaori Shima y Tomonori Sasahira. "Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer". PLOS ONE 19, n.º 5 (31 de mayo de 2024): e0300446. http://dx.doi.org/10.1371/journal.pone.0300446.
Texto completoLin, Xin, Min Xiao, Zhitao Chen, Chenchen Ding, Ting Zhang y Qiyong Li. "Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors". Journal of Oncology 2022 (23 de mayo de 2022): 1–40. http://dx.doi.org/10.1155/2022/6115878.
Texto completoZhou, Yiyi, Shuangshuang Xu, Qinying Sun y Yuchao Dong. "An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer". Disease Markers 2022 (11 de octubre de 2022): 1–28. http://dx.doi.org/10.1155/2022/7899961.
Texto completoOu, Qiyun, Yunfang Yu, Haitao Zhong, Anlin Li, Yongjian Chen, HaiYu Zhou, Shaopeng Zheng, Luyu Huang y Herui Yao. "Association of immune-related adverse events with immune checkpoint inhibitor efficacy in pancancer." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): e14087-e14087. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14087.
Texto completoLiu, Ranran, Tianyu Li, Guohong Zhang, Yejuan Jia, Jingxuan Liu, Lijia Pan, Yunfeng Li y Chunsheng Jia. "Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell". Stem Cells International 2023 (12 de mayo de 2023): 1–17. http://dx.doi.org/10.1155/2023/8485726.
Texto completoNiederhausern, Andrew, Nadia S. Bahadur, Gary Wallace, Gilan E. Saadawi y John Philip. "Abstract 4966: Machine learning and large language model approach to pancancer data elements". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 4966. http://dx.doi.org/10.1158/1538-7445.am2024-4966.
Texto completoGong, Xiaoming, Tao Chen, Cheyu Lin, Haiqin Ping, Xin Tong, Kai Zhang, Zhaojun Chen, Caiyun Cai, Zhiyan Lu y Hengning Ke. "Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening". BioMed Research International 2023 (17 de abril de 2023): 1–13. http://dx.doi.org/10.1155/2023/2501596.
Texto completoWu, Zixuan, Yanhui Jiang, Xuyan Huang, Minjie Cai, Kai Yuan, Peidong Huang y Zuhong Wang. "In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis". Evidence-Based Complementary and Alternative Medicine 2022 (15 de abril de 2022): 1–12. http://dx.doi.org/10.1155/2022/7730433.
Texto completoYang, Ziyue, Yuanyuan Zhu, Zhenfen Li, Zhangya Pu, Ying Lin, Ying Deng, Ning Li y Fang Peng. "Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4". Computational and Mathematical Methods in Medicine 2022 (17 de diciembre de 2022): 1–24. http://dx.doi.org/10.1155/2022/2528164.
Texto completoLiu, Qiaojun, Renjian Xie y Yumei Li. "Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival". International Journal of Molecular Sciences 23, n.º 17 (25 de agosto de 2022): 9611. http://dx.doi.org/10.3390/ijms23179611.
Texto completoEl-Deiry, Wafik S., Taylor Arnoff, Ilyas Sahin, Hossein Borghaei, Vivek Subbiah, Hina Khan, Benedito A. Carneiro et al. "A pancancer analysis of impact of MDM2/MDM4 on immune checkpoint blockade (ICB)." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 2630. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2630.
Texto completoDouglass, Eugene F., Robert J. Allaway, Bence Szalai, Wenyu Wang, Tingzhong Tian, Adrià Fernández-Torras, Ron Realubit et al. "A community challenge for a pancancer drug mechanism of action inference from perturbational profile data". Cell Reports Medicine 3, n.º 1 (enero de 2022): 100492. http://dx.doi.org/10.1016/j.xcrm.2021.100492.
Texto completoGao, Chao, Xiangqin Fan, Yanyan Liu, Yanyan Han, Shiqi Liu, Huanrong Li, Qiaoling Zhang, Yingmei Wang y Fengxia Xue. "Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer". International Journal of General Medicine Volume 16 (diciembre de 2023): 5817–39. http://dx.doi.org/10.2147/ijgm.s438479.
Texto completoLu, Jianyun, Jasmin Sponagel, Jill Jones, Hannah Gass, Elena Nunez, Cheryl Frankfater, Sierra Williams-McLeod et al. "TMET-13. SEX DIFFERENCES IN GLUCOSE METABOLISM AND MITOCHONDRIAL FUNCTION IN GLIOBLASTOMA IMPLICATE HYPOXIA-INDUCIBLE FACTOR 1 ALPHA (HIF1A) ACTIVITY". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii264. http://dx.doi.org/10.1093/neuonc/noac209.1018.
Texto completoDeng, Chao, Hang Guo, Dongliang Yan, Tao Liang, Xuxiao Ye y Zuowei Li. "Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma". BioMed Research International 2021 (15 de abril de 2021): 1–31. http://dx.doi.org/10.1155/2021/5546612.
Texto completoMiyashita, Hirotaka, Nicholas J. Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Sean Glenn et al. "Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 2555. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2555.
Texto completoNiavarani, Ahmadreza, Asieh Shahrabi Farahani, Maryam Sharafkhah y Minoo Rassoulzadegan. "Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions". Carcinogenesis 39, n.º 3 (13 de enero de 2018): 327–35. http://dx.doi.org/10.1093/carcin/bgy005.
Texto completoArigbede, Olumide, Sarah G. Buxbaum, Sara Falzarano y Suhn Rhie. "Abstract A078: Exploration, analysis and visualization of TCGA pancancer data in the cBioPortal: Prostate adenocarcinoma genomics". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 1_Supplement (1 de enero de 2023): A078. http://dx.doi.org/10.1158/1538-7755.disp22-a078.
Texto completoChampion, Magali, Kevin Brennan, Tom Croonenborghs, Andrew J. Gentles, Nathalie Pochet y Olivier Gevaert. "Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response". EBioMedicine 27 (enero de 2018): 156–66. http://dx.doi.org/10.1016/j.ebiom.2017.11.028.
Texto completoReckamp, Karen L., Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke, Tamara Mirzapoiazova et al. "Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations". Future Science OA 7, n.º 2 (febrero de 2021): FSO662. http://dx.doi.org/10.2144/fsoa-2020-0159.
Texto completoWu, Zixuan, Dongli Jiang, Xuyan Huang, Minjie Cai, Kai Yuan y Peidong Huang. "S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis". Journal of Oncology 2022 (18 de marzo de 2022): 1–15. http://dx.doi.org/10.1155/2022/6947652.
Texto completoWu, Yumeng, Xuming Wu, Yuanyuan Li, Wenjing Zhao, Yanping Yue, Biao Wu, Jibin Liu, Xudong Chen y Aiguo Shen. "Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer". BioMed Research International 2021 (27 de septiembre de 2021): 1–16. http://dx.doi.org/10.1155/2021/8201377.
Texto completoLi, Xuanyi, Ben Ho Park, Justin M. Balko y Douglas Buckner Johnson. "Pathway enrichment analysis in tumors with high mutation burdens and interferon-γ signature expression: A pancancer analysis." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): 3138. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3138.
Texto completoXu, Yining, Xinran Cui, Liyuan Zhang, Tianyi Zhao y Yadong Wang. "Metastasis-related gene identification by compound constrained NMF and a semisupervised cluster approach using pancancer multiomics features". Computers in Biology and Medicine 151 (diciembre de 2022): 106263. http://dx.doi.org/10.1016/j.compbiomed.2022.106263.
Texto completoDeng, Hui, Hanming Yao, Shurui Zhou, Chong He, Yuzhou Huang, Yunlong Li, Hanwei Chen y Jianchang Shu. "Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer". Molecular and Cellular Probes 73 (febrero de 2024): 101948. http://dx.doi.org/10.1016/j.mcp.2023.101948.
Texto completoHuang, Juntao, Ziqian Xu, Dahua Chen, Chongchang Zhou y Yi Shen. "Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors". Medicine 102, n.º 52 (29 de diciembre de 2023): e36830. http://dx.doi.org/10.1097/md.0000000000036830.
Texto completoInternational, BioMed Research. "Retracted: Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma". BioMed Research International 2024 (20 de marzo de 2024): 1. http://dx.doi.org/10.1155/2024/9802197.
Texto completoLeivonen, Suvi-Katri, Judit Jørgensen, Thomas Stauffer Larsen, Annika Pasanen, Marja-Liisa Karjalainen-Lindsberg, Helle M. Toldbod, Francesco d'Amore y Sirpa Leppa. "Molecular Profiling of Aggressive Non-Hodgkin Lymphoma - Results from a Phase 1/2 Preben Study". Blood 134, Supplement_1 (13 de noviembre de 2019): 5314. http://dx.doi.org/10.1182/blood-2019-129113.
Texto completo